Literature DB >> 22744648

Kindling-induced learning deficiency and possible cellular and molecular involved mechanisms.

Mohammad Amin Sherafat1, Abdolaziz Ronaghi, Leila Ahmad-Molaei, Mohammad Nejadhoseynian, Rasoul Ghasemi, Arman Hosseini, Nima Naderi, Fereshteh Motamedi.   

Abstract

Hippocampus learning disturbance is a major symptom of patients with seizure, hence hippocampal dysfunction has essential role in worsening the disease. Hippocampal formation includes neurons and myelinated fibers that are necessary for acquisition and consolidation of memory, long-term potentiation and learning activity. The exact mechanism by which seizure can decrease memory and learning activity of hippocampus remains unknown. In the present study, electrical kindling-induced learning deficit in rats was evaluated by Morris water maze (MWM) test. The hippocampus was removed and changes in neurons and myelin sheaths around hippocampal fibers were investigated using histological and immunohistochemical methods. Demyelination was assessed by luxol fast blue staining, and immunohistological staining of myelin-binding protein (MBP). The TUNEL assay was used for evaluation of neuronal apoptosis and the glial fibriliary acetic protein (GFAP) was used for assessment of inflammatory reaction. The results indicated that electrical kindling of hippocampus could induce deficiency in spatial learning and memory as compared to control group. In addition, electrical kindling caused damage to the myelin sheath around hippocampal fibers and produced vast demyelination. Furthermore, an increase in the number of apoptotic cells in hippocampal slices was observed. In addition, inflammatory response was higher in kindled animals as compared to the control group. The results suggested that the decrease in learning and memory in kindled animals is likely due to demyelination and augmentation in apoptosis rate accompanied by inflammatory reaction in hippocampal neurons of kindled rats.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22744648     DOI: 10.1007/s10072-012-1142-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  32 in total

Review 1.  The medial temporal lobe memory system.

Authors:  L R Squire; S Zola-Morgan
Journal:  Science       Date:  1991-09-20       Impact factor: 47.728

2.  Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures.

Authors:  J Bengzon; Z Kokaia; E Elmér; A Nanobashvili; M Kokaia; O Lindvall
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

3.  Regulation of fibroblast cyclooxygenase synthesis by interleukin-1.

Authors:  A Raz; A Wyche; N Siegel; P Needleman
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

4.  A permanent change in brain function resulting from daily electrical stimulation.

Authors:  G V Goddard; D C McIntyre; C K Leech
Journal:  Exp Neurol       Date:  1969-11       Impact factor: 5.330

5.  Spatial learning deficits and emotional impairments in pentylenetetrazole-kindled rats.

Authors:  Farzad Mortazavi; Mathew Ericson; Darren Story; Verne D Hulce; Gary L Dunbar
Journal:  Epilepsy Behav       Date:  2005-10-24       Impact factor: 2.937

6.  Induction of the complement component C1qB in brain of transgenic mice with neuronal overexpression of human cyclooxygenase-2.

Authors:  Lauren Spielman; David Winger; Lap Ho; Paul S Aisen; Esther Shohami; Giulio Maria Pasinetti
Journal:  Acta Neuropathol       Date:  2001-11-24       Impact factor: 17.088

7.  Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice.

Authors:  D M Calida; C Constantinescu; E Purev; G X Zhang; E S Ventura; E Lavi; A Rostami
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

Review 8.  Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases.

Authors:  Luisa Minghetti
Journal:  J Neuropathol Exp Neurol       Date:  2004-09       Impact factor: 3.685

9.  Neuronal activity up-regulates astroglial gene expression.

Authors:  O Steward; E R Torre; R Tomasulo; E Lothman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

10.  Glial response to neuronal activity: GFAP-mRNA and protein levels are transiently increased in the hippocampus after seizures.

Authors:  E R Torre; E Lothman; O Steward
Journal:  Brain Res       Date:  1993-12-24       Impact factor: 3.252

View more
  5 in total

1.  De-repression of myelin-regulating gene expression after status epilepticus in mice lacking the C/EBP homologous protein CHOP.

Authors:  Caroline Sheedy; Claire Mooney; Eva Jimenez-Mateos; Amaya Sanz-Rodriguez; Elena Langa; Catherine Mooney; Tobias Engel
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2014-12-15

2.  Anticonvulsant Effect of Swertiamarin Against Pilocarpine-Induced Seizures in Adult Male Mice.

Authors:  Xian-Hua Deng; Xiao Zhang; Jing Wang; Peng-Sheng Ma; Lin Ma; Yang Niu; Tao Sun; Ru Zhou; Jian-Qiang Yu
Journal:  Neurochem Res       Date:  2017-07-05       Impact factor: 3.996

3.  Antiepileptogenic effects of borneol in pentylenetetrazole-induced kindling in mice.

Authors:  Rufi Tambe; Pankaj Jain; Sachin Patil; Priya Ghumatkar; Sadhana Sathaye
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-02-18       Impact factor: 3.000

4.  Neuroprotective Effect of Coumarin Nasal Formulation: Kindling Model Assessment of Epilepsy.

Authors:  Suraj Muke; Aakruti Kaikini; Vaibhavi Peshattiwar; Sneha Bagle; Vikas Dighe; Sadhana Sathaye
Journal:  Front Pharmacol       Date:  2018-09-03       Impact factor: 5.810

5.  The Calcineurin Inhibitor FK506 Prevents Cognitive Impairment by Inhibiting Reactive Astrogliosis in Pilocarpine-Induced Status Epilepticus Rats.

Authors:  Jinzhi Liu; Zhihua Si; Shuqing Li; Zhan Huang; Yan He; Tao Zhang; Aihua Wang
Journal:  Front Cell Neurosci       Date:  2018-01-09       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.